EUVIMEDEUVIMED entdecken
Crossref

Mechanisms and Therapeutic Potential of Gongronema latifolium in Sickle Cell Disease

Nnodim Johnkennedy *, Uzodima Udoha Augustine, Nwanguma Eberechi Doris

Clinical Endocrinology and Metabolism · 27.02.2026 · 05 (01) · 01-04

DOI: 10.31579/2834-8761/102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Endocrinology and Metabolism, online erschienen am 27.02.2026. Verfasst von Nnodim Johnkennedy * und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Abnormal haemoglobin polymerisation, red blood cell deformation, chronic haemolysis, vaso-occlusion, and systemic inflammation are the hallmarks of sickle cell disease (SCD), a genetic hemoglobinopathy. Many patients in developing nations rely on medicinal plants as supplemental therapies despite advancements in management. The tropical medicinal plant Gongronema latifolium Benth., which is commonly used in West Africa, has drawn notice for its haematopoietic, antioxidant, anti-inflammatory, and antisickling qualities. This article examines G. latifolium's pharmacodynamics in relation to sickle cell disease, emphasising its bioactive phytochemicals and modes of action. The plant contains flavonoids, alkaloids, saponins, tannins, and phenolic compounds that can reduce inflammation, improve erythrocyte membrane stability, modulate oxidative stress, and inhibit haemoglobin S polymerisation, according to experimental research. These pharmacodynamic effects imply that G. latifolium might be helpful in sickle cell disease treatment. To confirm its effectiveness, find the best dosage, and create safety profiles for long-term therapeutic use, more clinical trials are needed.

Zitieren

APA

*, N. J., Augustine, U. U., & Doris, N. E. (2026). Mechanisms and Therapeutic Potential of Gongronema latifolium in Sickle Cell Disease. Clinical Endocrinology and Metabolism, 05(01), 01-04. https://doi.org/10.31579/2834-8761/102

Vancouver

* NJ, Augustine UU, Doris NE. Mechanisms and Therapeutic Potential of Gongronema latifolium in Sickle Cell Disease. Clinical Endocrinology and Metabolism. 2026;05(01):01-04. doi:10.31579/2834-8761/102

BibTeX
@article{2026,
  author = {*, Nnodim Johnkennedy and Augustine, Uzodima Udoha and Doris, Nwanguma Eberechi},
  title = {Mechanisms and Therapeutic Potential of Gongronema latifolium in Sickle Cell Disease},
  journal = {Clinical Endocrinology and Metabolism},
  year = {2026},
  volume = {05},
  number = {01},
  pages = {01--04},
  doi = {10.31579/2834-8761/102}
}
Kostenlos starten →